Found 192 results in Expert Content

Clarifying the myths surrounding LBDSS which may make drug developers consider it in parallel to other formulation approaches

Developers are looking for ways to predict and overcome potential issues of new molecular entities

Gain more knowledge on dysphagia, which is one of the major factors affecting medication adherence and proper medication administration.

A connected, data-driven approach to managing bioavailability challenges in new chemical entities

Developing specific dosing guidelines and acceptable dosage forms for pediatric patients to optimize therapeutic efficacy and limit and prevent serious adverse side effects.

Leveraging knowledge about an API’s physiochemical properties from preformulation and formulation studies increases the chances of early-phase success.

Developing a tailored package of analysis to ensure compliance with regulatory guidelines.

Innovative dose forms to expand and improve your product line.

This webcast discusses key concepts that should be addressed as a molecule advances through the clinical development phases

The use of Pre-clinical tools to study pharmacokinetics, choose a lead drug candidate and move that product into development.